A neurosurgery is made by Helicase 4 to 6 genes of Epstein Barr Virus (4 to 6 Helicase gene of EBV); for this was it is made to surge tumor cells in patients of Medulloblastoma and Glioma in both animals and human clinical trial phase-III. In this case it will act by surgical procedure himself (surgical Neurooncology procedure) by acting as neurosurgeon inside tumor cells in both patients of Medulloblastoma and Glioma of human and mice phase –III; in this case the well doing is seizure of gene 5 of EBV and the other is scalpel. Of these tumors (Medulloblastoma and Glioma) of animal cells and human 10% were fully treated by removing NOTCHES of c-AMP of Medulloblastoma (neuroprimitive ectodermal tumors of cerebellum in embryo and children) and primitive neuroectodermal sheath of skull (Glioma in young and adults) by Helicase gene 4 and 6 (scalpel process). Other issue is to find a medium inside cerebrospinal fluid (CSF) of both tumors by Helicase gene itself in destroying plasmodesmata between cells of tumor by artificial plasmosomes (synthesized in self-funded laboratories). The EBV is fully power in its enzyme (Helicase gene from 4 to 6 with fully length density 2000 of plasmosomes due to it will act as a neurosurgeon in its needed. Other thing it will act as scalpel in its issue without any toxic side effects.
Spontaneous pneumothorax is regarded as a common and benign clinical entity, however, it can be life-threatening if it progress to tension pneumothorax. While tension pneumothorax can develop abruptly, cardiovascular compromise progress more gradually due to the existence of a compensatory mechanism. A 30-year-old Thai male, previously healthy, who presented with left-sided spontaneous pneumothorax. He informed physician that his mother was previously diagnosed as secondary pneumothorax and underwent pleurodesis. He underwent video-assisted thoracoscopic for pleurodesis. Additional investigation showed multiple lung cysts in Computerized Tomography Scan. Birt-Hogg Dube syndrome was confirmed genetically by FLCN gene mutation.
Various microorganisms e.g., bacteria, fungi and higher organism e.g., plant during their metabolism produces both primary and secondary metabolites, needed for their survival and defense. Often these secondary metabolites are being used in drug discovery. The genes for the enzymes of these secondary metabolic pathways are generally grouped together as biosynthetic gene clusters (BGCs) and hidden away in organism’s genome. Genome mining of the unexplored microbes, medicinal plants, and underexplored human microbiota with emerging genomics research involving next-generation sequencing technology along with bioinformatics tools like anti-SMASH (antibiotics and Secondary Metabolite Analysis Shell), planti-SMASH, may help in finding many BGCs and subsequently in the discovery of many new drugs in future.
Apoptosis is a way for loss of unwanted cells during homeostasis, development, and integrity of tissues which is a process depending on caspases started through extrinsic and intrinsic or mitochondrial pathways. During a bioinformatics survey, important targeting miRs in both pathways have been identified. In the current study, due to common biochemical origin of apoptosis and differentiation, the role of hsa-miR-765 during the course of apoptosis induction and cardiomyocytes differentiation of hESCs have been investigated. We found the expression of BAX, BAK1, and BOK as the key elements of mitochondrial membrane pores involved in apoptosis induction and targeted by this miRNA during apoptosis and differentiation. All data represented here may disclose the imperative function of hsa-miR-765 in discrimination of biochemical aspect of differentiation and apoptosis of embryonic stem cells towards cardiomyocytes.
One of the most significant developments in cell and developmental biology in recent years has been the incredible interest in the potential of stem cells in regenerative medicine. ln spite of the ongoing political, ethical and scientific challenges interest in the potential clinical utility of stem continues to increase. Extraordinary developments in the field of stem cell research continued in developing disease-specific stem cell lines; advances were made in creating induced pluripotent stem (iPS) cell lines using technologies compatible with clinical use; and the US Food and Drug Administration (FDA) gave approval for the first clinical trial using cells derived from human embryonic stem cells (hESC) for the treatment of spinal cord injury. Both regenerative medicine and tissue engineering rely on the success of stem cell technology. Advances in the embryonic and adult stem cell research, particularly over the past two decades, have enabled cell-based therapies. Now it is also possible to genetically reprogram the somatic cells and induce pluripotency in them to function in a manner similar to embryonic stem cells. However, further studies on teratogenic or tumorigenic properties, cellular dose, cell proliferation, senescence, karyotyping, and immunosuppressive activity are essential to translate the technology into clinical application.
The purpose of this meta-analysis was to assess the association between Gender and Burn out syndrome among health care workers in Ethiopia. Previous findings on the association of gender and burn out syndrome have reported different results. We use data from four studies to do a metaanalysis. We applied the random-effects analytic model and calculated a pooled odds ratio. The odds ratios for all studies revealed no statistically significant association of Burn out syndrome with Male relative to Female (OR = 1.15; 95% CI: 0.48-2.71, Heterogeneity: Tau² = 0.55; Chi² = 12.17, df = 3 (P = 0.007); I² = 75%, Test for overall effect: Z = 0.31 (P = 0.76). The proportion of Burn out syndrome among male and female health professionals is 31.31% (578). 35.43% (302) respectively. The overall proportion of Burn out syndrome among health professionals is 32.73% (880).
